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PS-03 Endocrine Pathology 
PS-03-002 
Prognostic criteria for pituitary adenomas 
L, Mitrofanova*, P. Konovalov, O. Raspopova. U. Tsoy Federal Almazov 
Centre, Dept, of Pathology, St. Petersburg. Russia 
Objective: To determine prognostic criteria for pituitary adenoma depending 
on hormone production. 
Method: We studied the hormonal state and Ki-67 prolifirative index in 142 
patients with pituitary adenomas. MRI was used to estimate the tumour size and 
to monitor its growth. Tumours exceeding 10 mm in size were defined as 
macroadenomas, and those smaller than or equal to 10 mm as microadenomas. 
Immunohistochemical staining was carried out with anti-bodies against Ki-67 
and 6 pituitary honnones. 
Results: Macroadenomas were mainly mammosomatotropinomas or 
gonadotropinomas with tumour with invasive growth and recurrence. 
Proliferative activities of micro- and macroadenomas were not significantly 
different. The average size of recurrent adenomas was 29 ± 12 mm (the non-
recurrent ones were 17,6± 10 mm, p< 0,001), their proliferative activities did 
not differ. The proliferative activity of invasive adenomas was significantly 
higher than in non-invasive. Gonadotropinomas were more often recurrent and 
demonstrated invasive growth without clinical signs of hormonal 
hypersecretion. 
Conclusion: Our study showed that the most part of gonadotropinomas did not 
have any clinical signs. In all the cases they were macroadenomas and often 
recurrent. The tumour proliferative activity more than 2,6 % can be used as a 
prognostic criterion only for gonadotropinomas. 
PS-03-003 
Somatostatin receptor subtype 2A and 5 expression in medullary 
thyroid carcinoma 
V. Delektorskaya*, G. Chemeris, A. Pavlovskaya Russian Cancer Research 
Centre, Dept, of Pathology, Moscow, Russia 
Objective: The aim of the study was to assess somatostatin receptor subtype 
2A and 5 (SSTR 2A and 5) expression and clinical significance in Medullary 
Thyroid Carcinoma (MTC). 
Method: Twenty-seven MTC patients were retrospectively evaluated. 
Immunohistochemical expression of receptors was studied in the primary and 
metastatic tumours using monoclonal antibodies against SSTR 2A (clone UMB-
1) and SSTR 5 (clone UMB-4). The staining results were correlated with 
various clinico-pathological and outcome parameters. Results: The diagnosis 
of MTC was based on the pathological features and positive immunoreactivity 
of the tumours for calcitonin and CEA. We identified the SSTR 5 as the most 
Sequent receptor subtype in these turnouts. SSTR 5 showed positive 
immunohistochemical expression in 16 of 27 (59.3 %) MTC samples as 
compared to 8 of27 (29.6 %) for SSTR 2A. No case showed only SSTR 2A 
expression. Analysis of primary tumours and their lymph node me- tastases 
revealed a similar pattern of SSTR immunoreactivity. SSTR 2A and SSTR 5 
protein expression was not related to clinical parameters or outcome. 
Conclusion: The presence of SSTR 2A and 5 receptors in MTCs may be an 
important indication for the diagnostic procedures and targeted therapy with 
somatostatin peptide radioligands. A prognostic value of these markers should 
be further evaluated. 
PS-03-004 
Morphological study of papillary thyroid carcinoma with 
biomineralization 
R. Moskalenko*, A. Romaniuk, M. Lyndin, A. Rieznik 
*Sumy State University, Dept, of Pathology, Ukraine 
Objective: Papillary thyroid carcinoma (PTCa) is the most common form of 
malignant tumours of this organ, covering approximately 70 % in the structure 
of morbidity. One of important prognostic PTCa factors is pathological 
biomineralization. The purpose is to study morphological value of 
biomineralization in papillary thyroid cancer. 
Method: Histological, histochemical techniques and scanning electron 
microscopy with microanalysis and X-ray diffraction were used to study the 
samples of PTCa. 
Results: The first group of patients included 27 women and 3 men and the 
average age was 56.93 ±2.18 years old. In patients with symptoms of miner-
alization the largest tumour size was 1,84 ± 0,13 cm, in seven cases metastases 
were found in peripheral lymph nodes. Patients, who had no signs of PTCa 
mineralization, made up the second group of 30 people—24 women and 6 men. 
The laigest tumour size averaged 1,44 ±0,09 cm (p<0.07), in eight cases 
metastases were found in peripheral lymph nodes. Comparing the number of 
patients with metastases in both groups (7—Group I, 8—Group II) and 
describing the size of tumour, subject to presence and absence of metastases in 
patients (2,09±0,2 cm and 1,31 ±0,17 cm), there was significant difference 
found between indicators of clinical cases of studied groups (p < 0.02). 
Conclusion: Mineralized samples of papillary thyroid cancer reach larger 
compared to cases without evidence of calcification. Comparing the first and 
second series of samples PTCa showed no connection between bio-
mineralization and age of patients. Hydroxyapatite is the main mineral, which is 
formed during pathological biomineralization PTCa. 
PS-03-005 
Synchronous pheocromocytoma and gastrointestinal stromal tumour 
in a patient with germline mutation in the TMEM127 gene 
J. Cameselle Teijeiro* , N. Escudero Garcia, A. Vazquez Boquete, M. Piso 
Neira, E. Couso Folgueiras, Y. Rico, J. M. Cabezas Agricola. L. Loidi  
*Clinical University Hospital, Dept, of Pathology, Santiago dе  
Compostela, Spain 
 
Objective: Germline mutations in the TMEM127 (transmembrane protein 127) 
gene have been detected in familial pheocromocytoma paraganglioma and more 
recently in familial pheochromomoma and renal cell carcinoma syndrome. 
Camey-Stratakis syndrome (Carney dyad) is characterized by a 
pheocromocytoma (PHEO)/gastrointestinal stromal tumour (GIST) dyad, 
secondary to SDHB, SDHC or SDHD gene mutations. We report a synchronous 
PHEO and GIST case in an individual with TMEM127 germline mutation. 
Method: A 70-year-old woman presented with both a left adrenal nodule and a 
small gastric tumour (antrum wall), incidentally discovered during follow-up 
for horseshoe kidney. Both tumours (101 and 35 mm respectively) were excised 
with pathological, immunohistochemical and molecular stucjies following. 
Results: Pathological examination showed a PHEO immunopositive for 
chromogranin, synaptophysin and Ki-67(<1 %) but negative for cytokeratins 
(AE1/AE3). The GIST was positive for CD34, CD117(c- kit), DOG1, smooth 
muscle actin (focal) and Ki-67 (5 %) but negative for cytokeratins, desmin and 
S100. Sequencing analysis was used for KIT gene screening in the PHEO and 
for KIT and PDGFRB in the GIST with negative results. Germline mutational 
analysis showed a heterozygous missense mutation in exon 4 of TMEM127: 
NM 017849.3:c.620C>T (p.Ala207Val) (Chr2(GRCh37):g.96919643G>A). 
Conclusion: This is the first case of synchronous PHEO and GIST (Carney 
dyad) associated with germline mutation in the TMEM127 gene. 
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Thyroid findings in a patient with Birt-Hogg-Dube syndrome 
J. Cameselle Teijeiro*, S. Garcia Acuna, J. Caneiro, M. Sanchez Ares, R. Perez 
Becerra, I. Abdulkader, A. Vega Gliemmo  
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